Total Cost of Revenue
Becton, Dickinson and Company Total Cost of Revenue decreased by 9.9% to $2.56B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.3%, from $2.62B to $2.56B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows relatively stable performance with a 2.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
A decrease relative to revenue suggests improved manufacturing efficiency or better supply chain cost control.
Detailed definition
Total cost of revenue includes all direct costs attributable to the production of goods and the delivery of services sol...
Peer comparison
Standard metric; peers in manufacturing typically maintain consistent margins based on production scale.
total_cost_of_revenueHistorical Data
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.65B | $2.76B | $2.50B | $2.64B | $2.57B | $2.68B | $2.45B | $2.59B | $2.78B | $3.39B | $2.68B | $2.74B | $2.68B | $2.95B | $2.93B | $2.62B | $2.88B | $3.09B | $2.84B | $2.56B |
| QoQ Change | — | +4.3% | -9.6% | +5.6% | -2.4% | +4.3% | -8.6% | +5.4% | +7.4% | +21.9% | -20.9% | +2.3% | -2.1% | +10.0% | -0.6% | -10.7% | +9.8% | +7.5% | -8.1% | -9.9% |
| YoY Change | — | — | — | — | -2.8% | -2.8% | -1.8% | -1.9% | +7.9% | +26.2% | +9.2% | +6.0% | -3.4% | -12.9% | +9.5% | -4.5% | +7.2% | +4.8% | -3.1% | -2.3% |
Business Segments
| Segment | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Medical Essentials | — | — | — | — | — | — | — | $835.00M |
| Connected Care | — | — | — | — | — | — | — | $490.00M |
| Interventional | — | — | — | — | — | — | — | $429.00M |
| BioPharma Systems | — | — | — | — | — | — | — | $316.00M |
| Life Sciences | $622.25M | $634.50M | $634.50M | $634.50M | $634.50M | $385.00M | $393.00M | — |
| Total | $3.39B | $2.68B | $2.74B | $2.68B | $2.95B | $2.93B | $2.84B | $2.56B |
Medical is derived from annual filings.
Life Sciences was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
Total Cost of Revenue at Other Companies
Frequently Asked Questions
- What is Becton, Dickinson and Company's total cost of revenue?
- Becton, Dickinson and Company (BDX) reported total cost of revenue of $2.56B in Q1 2026.
- How has Becton, Dickinson and Company's total cost of revenue changed year-over-year?
- Becton, Dickinson and Company's total cost of revenue decreased by 2.3% year-over-year, from $2.62B to $2.56B.
- What is the long-term trend for Becton, Dickinson and Company's total cost of revenue?
- Over 4 years (2021 to 2025), Becton, Dickinson and Company's total cost of revenue has grown at a 2.0% compound annual growth rate (CAGR), from $10.66B to $11.52B.
- What does total cost of revenue mean?
- The direct costs incurred to produce the goods or services sold by the company.